This was one of the first works to demonstrate that crosstalk between astrocytes and microglia is an important regulator of the glial reactivity state
Pauling This Pharmacology Consult will focus on GLP-1 receptor agonists that are currently FDA approved for weight loss, including semaglutide (Wegovy, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk), but other FDA-approved options exist, such as orlistat, naltrexone/bupropion and phentermine/topiramate
BPC-157 and TB-500 are both associated with angiogenesis, but through different proposed mechanisms
The FDA has approved these medications for use in patients with type 2 diabetes and for weight loss in individuals meeting certain criteria, such as BMI and weight-related conditions
A.XerezM
Ph n t 30 tui mun tr ha ln da, lm sng da, p da